$10.42
10.26% yesterday
NYSE, Oct 20, 10:00 pm CET

Fortrea Stock price

$10.42
+0.78 8.09% 1M
+5.22 100.38% 6M
-8.23 44.13% YTD
-8.51 44.96% 1Y
-19.68 65.38% 3Y
-19.68 65.38% 5Y
-19.68 65.38% 10Y
-19.68 65.38% 20Y
NYSE, Closing price Mon, Oct 20 2025
+0.97 10.26%

Key metrics

Basic
Market capitalization
$946.1m
Enterprise Value
$2.0b
Net debt
$1.1b
Cash
$81.2m
Shares outstanding
90.8m
Valuation (TTM | estimate)
P/E
negative | 18.5
P/S
0.3 | 0.4
EV/Sales
0.8 | 0.8
EV/FCF
negative
P/B
1.6
Financial Health
Equity Ratio
38.1%
Return on Equity
-24.1%
ROCE
-3.9%
ROIC
-3.2%
Debt/Equity
2.0
Financials (TTM | estimate)
Revenue
$2.7b | $2.7b
EBITDA
$8.2m | $105.9m
EBIT
$-72.9m | $151.1m
Net Income
$-1.0b | $51.3m
Free Cash Flow
$-103.1m
Growth (TTM | estimate)
Revenue
-5.0% | -0.4%
EBITDA
-79.3% | 499.6%
EBIT
-39.9% | 235.2%
Net Income
-255.9% | 115.6%
Free Cash Flow
-145.6%
Margin (TTM | estimate)
Gross
19.7%
EBITDA
0.3% | 3.9%
EBIT
-2.7%
Net
-37.6% | 1.9%
Free Cash Flow
-3.8%
More
EPS
$-11.3
FCF per Share
$-1.1
Short interest
17.4%
Employees
15k
Rev per Employee
$190.0k
Show more

Is Fortrea a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Fortrea Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Fortrea forecast:

1x Buy
6%
10x Hold
63%
5x Sell
31%

Analyst Opinions

16 Analysts have issued a Fortrea forecast:

Buy
6%
Hold
63%
Sell
31%

Financial data from Fortrea

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,734 2,734
5% 5%
100%
- Direct Costs 2,194 2,194
8% 8%
80%
539 539
9% 9%
20%
- Selling and Administrative Expenses 531 531
17% 17%
19%
- Research and Development Expense - -
-
-
8.20 8.20
79% 79%
0%
- Depreciation and Amortization 81 81
12% 12%
3%
EBIT (Operating Income) EBIT -73 -73
40% 40%
-3%
Net Profit -1,027 -1,027
256% 256%
-38%

In millions USD.

Don't miss a Thing! We will send you all news about Fortrea directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fortrea Stock News

Neutral
GlobeNewsWire
6 days ago
DURHAM, N.C., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its third quarter 2025 financial results before the market opens on Wednesday, November 5, 2025. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question-and-an...
Neutral
GlobeNewsWire
29 days ago
DURHAM, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the appointment of William Sharbaugh to the Company's Board of Directors. Mr. Sharbaugh brings extensive healthcare experience in finance, operations, manufacturing, and quality to the position, having served in executive and board roles...
Neutral
GlobeNewsWire
about one month ago
DURHAM, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on September 12, 2025, to one newly hired employee. The award consisted of 75,000 RSUs that vest in three equal annual installments starting September 12, 2026, subject to ...
More Fortrea News

Company Profile

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.

Head office United States
CEO Peter Neupert
Employees 14,500
Founded 2023
Website www.fortrea.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today